Earnings Report April 28, 2004
NVE Reports Fiscal Year Results

EDEN PRAIRIE, Minn.--April 28, 2004--NVE Corporation (NasdaqSC: NVEC) today announced financial results for the fourth quarter and fiscal year ended March 31, 2004.

Total revenue for fiscal 2004 was $12.01 million compared to $9.45 million the prior year, an increase of 27%. Product sales increased 115% over the prior year. For fiscal 2004 the company reported net income of $2.11 million, including a net income tax benefit of $233,022 from reduction of the valuation allowance relating to deferred tax assets. This compares to net income of $646,850 in fiscal 2003. Earnings per share were $0.45 per diluted share compared to $0.15 per share for the prior year. The impact of the tax benefit in fiscal 2004 was $0.05 per share.

Total revenue for the fourth quarter of fiscal 2004 was $3.21 million compared to $2.60 million for the prior-year quarter, an increase of 23%. Product sales for the fourth quarter increased 94% over the prior-year quarter. Net income for the fourth quarter was $789,670 or $0.16 per diluted share compared $160,164 or $0.04 per share for the prior-year quarter. Net income for the fourth quarter included a net income tax benefit of $236,500 or $0.05 per share.

The company exceeded its previously issued guidance of net income of $0.30 to $0.37 per diluted share and revenue of between $11.5 and $12.0 million for fiscal 2004.

"We are very pleased with our results for the past year," commented President and Chief Executive Officer Daniel A. Baker, Ph.D. "Product sales grew very rapidly and our partners made significant strides toward production-ready MRAM."

NVE is a leader in the practical commercialization of spintronics, a nanotechnology which many experts believe represents the next generation of microelectronics. NVE licenses its MRAM intellectual property and sells spintronic products including sensors and couplers to revolutionize data sensing and transmission.

Statements used in this press release that relate to future plans, events, financial results or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, such factors as uncertainties relating to MRAM production by our licensees, our dependence on Cypress for potential supply of MRAM devices, risks relating to making commercially viable MRAMs, risks in the enforcement of our patents, as well as the risk factors listed from time to time in the company's filings with the SEC, including our Annual Report on Form 10-KSB and other reports filed with the SEC.

###
  
                            NVE Corporation
                  CONDENSED STATEMENTS OF OPERATIONS
            QUARTER AND YEAR ENDED MARCH 31, 2004 AND 2003
              (IN THOUSANDS EXCEPT PER SHARE; UNAUDITED)

Quarter ended                           March 31, 2004  March 31, 2003
Revenue:
  Contract research and development           $ 1,667         $ 1,709
  Product sales                                 1,541             795
  License revenue                                   -              98
                                        --------------  --------------
Total revenue                                   3,208           2,602

Cost of sales                                   1,890           1,638
                                        --------------  --------------
Gross profit                                    1,318             964

Expenses
  Research and development                        391             364
  Selling, general and administrative             441             513
                                        --------------  --------------
Total expenses                                    832             877
                                        --------------  --------------
Income from operations                            486              87

Interest Income                                    49              57
Interest expense                                   (5)             (8)
Other Income                                       23              24
                                        --------------  --------------
Income from operations before income taxes        533             160

Income tax (benefit)                             (237)              -
                                        --------------  --------------
Net income                                    $   790         $   160
                                        ==============  ==============

Weighted average shares outstanding             4,877           4,366
Net income per share - diluted                $  0.16         $  0.04


Year ended                              March 31, 2004  March 31, 2003
Revenue:
  Contract research and development           $ 6,617         $ 6,553
  Product sales                                 5,393           2,503
  License revenue                                   -             391
                                        --------------  --------------
Total revenue                                  12,010           9,447
Cost of sales                                   7,445           5,911
                                        --------------  --------------
Gross profit                                    4,565           3,536
Expenses
  Research and development                      1,103           1,308
  Selling, general and administrative           1,831           1,838
                                        --------------  --------------
Total expenses                                  2,934           3,146
                                        --------------  --------------
Income from operations                          1,631             390
Interest Income                                   189             211
Interest expense                                  (25)            (40)
Other Income                                       80              86
                                        --------------  --------------
Income from operations before income taxes      1,875             647
Income tax (benefit)                             (233)              -
                                        --------------  --------------
Net income                                    $ 2,108         $   647
                                        ==============  ==============

Weighted average shares outstanding 4,727 4,324 Net income per share - diluted $ 0.45 $ 0.15 NVE Corporation CONDENSED BALANCE SHEETS MARCH 31, 2004 AND MARCH 31, 2003 (IN THOUSANDS) (UNAUDITED) March 31, March 31, 2004 2003 ASSETS Current assets: Cash $ 1,056 $ 596 Investment securities 6,489 5,880 Account Receivable, net 1,739 1,028 Inventories 1,150 841 Other current assets 547 170 ----------- ----------- Total current assets 10,981 8,515 Fixed assets 1,439 1,167 ----------- ----------- Total assets $ 12,420 $ 9,682 =========== =========== LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities Accounts payable 327 311 Accrued payroll and other 712 626 Other current liabilities 547 1,043 ----------- ----------- Total current liabilities 1,586 1,980 Long-term liabilities 101 223 ----------- ----------- Total liabilities 1,687 2,203 Shareholders' equity: Common stock 45 42 Additional paid-in capital 13,298 12,171 Accumulated other comprehensive income 90 73 Accumulated deficit (2,700) (4,807) ----------- ----------- Total shareholders' equity 10,733 7,479 ----------- ----------- Total liabilities and shareholders' equity $ 12,420 $ 9,682 =========== ===========